Novartis Gets OK For Blood Pressure Drug
Swiss pharmaceutical maker Novartis AG said Tuesday it has received U.S. approval for the hypertension drug Tekturna _ a potential blockbuster that has shown the ability to lower blood pressure more effectively than common treatments. Tekturna is the first new type of medicine in more than a decade for treating high blood pressure. Approval from the U.S. Food and Drug Administration makes the …
